Cellectis (CLLS) Notes Payables (2014 - 2016)
Cellectis (CLLS) recorded quarterly Notes Payables of $2.1 million in Q1 2016, down 0.68% quarter-over-quarter from $2.1 million in Q4 2015.
Cellectis (CLLS) Notes Payables (2014 - 2016) Analysis & Trends
Cellectis' Notes Payables history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2016.
- In Q1 2016, Notes Payables changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2016 stood at $2.1 million (changed N/A YoY), while the FY2015 annual figure was $2.1 million, up 98.06% from the prior year.
- Notes Payables was $2.1 million for Q1 2016 at Cellectis, down from $2.1 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.4 million in Q2 2015 to a low of $1.1 million in Q4 2014.
- Historically, Notes Payables has averaged $2.4 million across 3 years, with a median of $2.1 million in 2015.
- Biggest YoY gain for Notes Payables was 95.45% in 2015; the steepest drop was 95.45% in 2015.
- A 3-year view of Notes Payables shows it stood at $1.1 million in 2014, then jumped by 95.45% to $2.1 million in 2015, then slipped by 0.68% to $2.1 million in 2016.
- The last three Notes Payables figures came in at $2.1 million (Q1 2016), $2.1 million (Q4 2015), and $3.3 million (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 2.09 Mn |
| Dec 31, 2015 | 2.11 Mn |
| Sep 30, 2015 | 3.32 Mn |
| Jun 30, 2015 | 3.35 Mn |
| Dec 31, 2014 | 1.08 Mn |